SHRIAHIMSA (SHRIAHIMSA) fundamentals
SHRIAHIMSA is a listed company, part of the Chemicals sector, listed on the NSE as SHRIAHIMSA (ISIN INE0DM401012). This page carries its reported financials, balance sheet, cash flow, shareholding pattern and valuation ratios.
What SHRIAHIMSA does
Shri Ahimsa Naturals Limited is an India-based company, which is engaged in the manufacturing and export of Caffeine Anhydrous Natural and Green Coffee Bean Extract. The Company is involved in the processing and exporting of Natural Caffeine, which is refined, processed and packaged. Its caffeine is used in manufacturing energy drinks, cola drinks, caffeinated water, sports drinks, and nutritional health & food supplements. The natural caffeine it offers, conforms to the quality standards recommended by United States Pharmacopoeia (USP), US Food and Chemical Codex (FCC), European Pharmacopoeia (EP), British Pharmacopoeia (BP), Indian Pharmacopeia (IP) and Japanese Pharmacopoeia. The Company’s product includes Ashwagandha P.E. 2.5% Withanolides by HPLC, Ashwagandha P.E. 2.5% Withanolides by Gravimetry, CO2 & Water Extracted Caffeine, Curcumin Extract, Garcinia Cambogia, White kidney Bean Extract, Senna Extract, Natural Caffeine Online, Green Coffee Bean Extract, and Tea Polyphenol.
Valuation and market data
| Last close | ₹465.00 |
|---|---|
| Market capitalisation | ₹878 crore |
| Enterprise value | ₹801 crore |
| P/E (TTM) | 0.00 |
| Price to book | 5.68 |
| Price to sales (TTM) | 0.00 |
| Book value per share | ₹81.86 |
| Dividend yield | 0.00% |
| Sector | Chemicals |
| Industry | — |
Annual results
| Period | Revenue | Profit before tax | Net profit | EPS |
|---|---|---|---|---|
| Mar 2026 | ₹130 crore | ₹40 crore | ₹30 crore | 0.00 |
| Mar 2025 | ₹98 crore | ₹30 crore | ₹22 crore | 11.64 |
| Mar 2024 | ₹79 crore | ₹25 crore | ₹19 crore | 10.21 |
| Mar 2023 | ₹106 crore | ₹51 crore | ₹36 crore | 68.21 |
| Mar 2022 | ₹59 crore | ₹16 crore | ₹11 crore | 24.28 |
Figures are as reported (standalone), in ₹ crore.
Shareholding pattern
As of Mar 2026:
| Promoters | 68.4% |
|---|---|
| Foreign institutions (FII) | 0.4% |
| Mutual funds | 0.0% |
| Other domestic institutions | 5.8% |
| Retail and others | 25.4% |
More on BreakPoint
FundaX company research covers every listed company with reported financials. BreakPoint Pro adds the BreakPoint iQ score, the screener and the multibagger board.
Data is sourced from exchange filings and vendor feeds and is for research, not investment advice. Figures can be restated by the company after publication.